Literature DB >> 3034791

Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma.

N E Skakkebaek, J G Berthelsen, A Giwercman, J Müller.   

Abstract

Based on evidence from morphological and histochemical studies and from clinical experience, the following hypotheses are proposed: carcinoma-in-situ (CIS) germ cells are malignant gonocytes; these CIS gonocytes have some capacity to regress into more primitive, totipotent embryonic cells which can give rise to all types of nonseminomatous germ cell tumours; the tumour germ cells of classical seminomas are malignant gonocytes derived from CIS gonocytes which have lost their ability to regress into totipotent embryonic cells; the ability of CIS gonocytes to regress into totipotent embryonic cells decreases with age, whereas the capacity to form classical seminoma cells is preserved; the transformation of CIS gonocytes into invasive tumours is dependent on factors such as gonadotrophins and/or testicular steroids; the pathogenesis of classical and spermatocytic seminoma are unrelated. As a consequence of these hypotheses an alternative nomenclature for carcinoma-in-situ, seminoma and dysgerminoma is suggested.

Entities:  

Mesh:

Year:  1987        PMID: 3034791     DOI: 10.1111/j.1365-2605.1987.tb00161.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  139 in total

1.  Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity.

Authors:  Thomas Mueller; Lutz Peter Mueller; Hans-Juergen Holzhausen; Ralf Witthuhn; Peter Albers; Hans-Joachim Schmoll
Journal:  Histochem Cell Biol       Date:  2010-06-08       Impact factor: 4.304

Review 2.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

Review 3.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2010-07-26       Impact factor: 7.196

4.  Risk of testicular cancer in subfertile men: case-control study.

Authors:  H Møller; N E Skakkebaek
Journal:  BMJ       Date:  1999-02-27

5.  X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.

Authors:  L H Looijenga; A J Gillis; R J van Gurp; A J Verkerk; J W Oosterhuis
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

6.  Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain.

Authors:  Rui Zhu; Yuan Ji; Lianchun Xiao; Angabin Matin
Journal:  Mamm Genome       Date:  2007-08-02       Impact factor: 2.957

Review 7.  Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation.

Authors:  C Ong; S Hasthorpe; J M Hutson
Journal:  Pediatr Surg Int       Date:  2005-02-23       Impact factor: 1.827

Review 8.  Conditions in utero and cancer risk.

Authors:  Tom Grotmol; Elisabete Weiderpass; Steinar Tretli
Journal:  Eur J Epidemiol       Date:  2006-09-13       Impact factor: 8.082

Review 9.  Carcinoma in situ in testicular biopsies.

Authors:  K Mazanec; I Vorechovsky
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

10.  Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ.

Authors:  J L Kang; E Rajpert-De Meyts; J Wiels; N E Skakkebaek
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.